Document is current
Any future updates will be listed below
-
Authors
Zhang, Enyao
Tian, Xin
Li, Ruoming
Chen, Chaoyang
Li, Min
Ma, Lingyun
Wei, Ran
Zhou, Ying
Cui, Yimin https://orcid.org/0000-0002-4186-1005
-
Funding
Funding for this research was provided by:
National Science and Technology Major Project for Significant New Drugs Development, Platform for Postmarketing Evaluation of New Drugs for Rare Diseases (2017ZX09304029-006-001)
National Science and Technology Major Project for Significant New Drugs Development, Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Pediatric Rare Diseases (2017ZX09304029-006)
National Science and Technology Major Project for Significant New Drugs Development, Platform for Research and Development and Industrialization of Pediatric Urgent Drugs in Short Supply (2017ZX09721003-008)
- License Information
-
More Information
Article History
Received: 19 October 2020
Accepted: 17 January 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
